thumbnail image

UE LifeSciences

  • Innovations 
    • iBreastExam
    • cervAIcal
  • About Us 
    • Journey
    • Team
  • Newsletter 
    • January 2023
    • 2022 Recap
  • Contact Us
  • …  
    • Innovations 
      • iBreastExam
      • cervAIcal
    • About Us 
      • Journey
      • Team
    • Newsletter 
      • January 2023
      • 2022 Recap
    • Contact Us
Stay Abreast

UE LifeSciences

  • Innovations 
    • iBreastExam
    • cervAIcal
  • About Us 
    • Journey
    • Team
  • Newsletter 
    • January 2023
    • 2022 Recap
  • Contact Us
  • …  
    • Innovations 
      • iBreastExam
      • cervAIcal
    • About Us 
      • Journey
      • Team
    • Newsletter 
      • January 2023
      • 2022 Recap
    • Contact Us
Stay Abreast
  • Our Journey

    { Pennsylvania Dept of Health Grant Award, Philadelphia }

  • Journey in Moments

    Inspiring. Surprising. Joyful.

    TED Talk with Shahrukh Khan
    Meeting Bill Gates
  • Journey in Time

    Transforming Dreams into Action

    2018 - 2021

    Starting to Scale

    • 8 Additional Regulatory Approvals & Distribution Partnerships (Mexico, Egypt, Southeast Asia, South Asia)
    • Broad Scale Validation with International KOLs (ASCO 2020, ASBS 2020, SABCS 2019, JCPCR 2018)
    • $400k in Grant & Awards from Pfizer Foundation, Bayer Cares Foundation, etc
    • New Patent Application Filed (July 2020)
    • iBreastExam 2nd Gen Sensor Invented, Developed New FDA/CE Mark & Made Production Ready
    • Business Collaboration with Pfizer (April 2021)
    • 650,000 women reached, $3M+ in cumulative revenue

    2015 - 2017

    Ramping Up

    • iBreastExam receives US FDA clearance, CE Mark
    • Manufacturing facility established in India (ISO 13485 and WHO:GMP certifications)
    • StartHealth Grant Award, Unitus Seed Fund ($80K).
    • $4.2M raised from Dr. Ranjan Pai, Mrs. Kiran Mazumdar Shaw  & Unitus Seed Fund
    • GE Healthcare obtains distribution rights for 25 Emerging Markets
    • Over 20,000 women served in various pilot programs across public and private healthcare partners, 
    • $1.5M in cumulative revenue + $400k in Grant Awards

    2009 - 2014

    Laying the Foundation

    • Founders kick-off operations with angel investment of $150,000 in Jan 2009
    • First Product  NoTouch BreastScan developed, two studies completed, FDA clearance, CE Mark
    • Sales in 5 countries, 5,000 women examined , $1.5M in cumulative revenues 
    • Pennsylvania Department of Health's CURE Grant Award for $878,000
    • Licensing agreement with Drexel University for new sensor technology commercialization 
    • iBreastExam commercial prototype developed by a multidisciplinary team of scientists, engineers and clinicians as a hand-held point-of-care device for use by community health workers
    • University City Science Center Digital Health Accelerator Award for $50,000
  • Founders' Note

    Mihir Shah

    "When you are looking at a disease like cancer from a family member's perspective, it takes a little while to learn and truly digest the fact this is a global scale challenge, one that's not being addressed and not going away anytime soon! Once the realization set in that it's not going to be an easy problem to solve is when I told myself that we have a real ballgame at hand."

    Matthew Campisi

    "Being touched personally by breast cancer certainly provides the passion and motivation to work hard for a solution. But when you realize the global breadth of the problem, you realize it's about so much more than yourself. It is an honor and a privilege to have this opportunity to be part of something with such global impact."

  • Leadership Team

    Advisors & Partners

    Our support systems

    Mihir Shah

    Founder & CEO

    Matt Campisi

    Co-Founder & CTO

    We are 68+ strong team

    Across 3 continents!

Home

Journey

Team

Newsletter

+1.267.225.0453

info@UELifeSciences.com

iBreastExam

cervAIcal

UE LifeSciences Inc. Copyright © 2021 | Terms & Conditions

    Invest
    News
    Call
    Email
Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More